Efficacy of different modes of fractional CO2 laser in the treatment of primary cutaneous amyloidosis A randomized clinical trial
Wausau, WI (July 7, 2015) – Research conducted by Samia M. Esmat, M.D., Marwa M. Fawzi, M.D., Heba I. Gawdat, M.D., Heba S. Ali, and Safinaz S. Sayed, M.D. was selected as Editor’s Choice in the July 2015 issue of Lasers in Surgery and Medicine (LSM).
The manuscript titled, “Efficacy of different modes of fractional CO2 laser in the treatment of primary cutaneous amyloidosis: A randomized clinical trial” was published in LSM, the official journal of the American Society for Laser Medicine and Surgery, Inc. (ASLMS).
Although there currently are various treatments for primary cutaneous amyloidosis (PCA), a condition in which amyloid or amyloid-like proteins are deposited in the dermis layer of skin, none are considered curative or satisfactory. This prompted a study to determine if applying different modes of a fractional CO2 laser would induce clinical and histological changes in PCA lesions.
Brian J.F. Wong, M.D., Ph.D., F.A.C.S, editor in chief of the Lasers in Surgery and Medicine journal commented on the study, "Fractional ablative CO2 lasers can effectively treat primary cutaneous amyloidosis. In the paper Efficacy of Different Modes of Fractional CO2 Laser in the Treatment of Primary Cutaneous Amyloidosis: A Randomized Clinical Trial by Gawdat et.al, fractional photothermolysis induced trans-epidermal elimination (TEE) is shown to be a mechanism of action in treatment of primary cutaneous amyloidosis.”
Dr. Wong is professor of otolaryngology-head and neck surgery, biomedical engineering, and surgery at the University of California-Irvine with his lab at the Beckman Laser Institute and Medical Clinic. He is also vice-chair of the department of otolaryngology-head and neck surgery, and fellowship director of the facial plastic surgery program at UC Irvine, and his clinical practice is divided between reconstructive and aesthetic surgery.
Editor’s Choice is an exclusive article published in LSM, the official journal of the ASLMS. To view the complete manuscript, visit: aslms.org/professional/lsmeditorschoice
The American Society for Laser Medicine and Surgery, Inc. (ASLMS) is the largest multi-disciplinary professional organization, dedicated to the development and application of lasers and related technology for health care applications. ASLMS promotes excellence in patient care by advancing biomedical application of lasers and other related technologies worldwide. Currently, ASLMS has over 4,000 members, including physicians and surgeons representing more than 51 specialties, physicists involved in product development, biomedical engineers, biologists, nurses, industry representatives and manufacturers. For more information, visit aslms.org.
- 30 -